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A pure leiomyoma of the prostate is a rare tumor. Less than 30 cases about prostatic leiomyoma have
been reported. Pathologic anatomy examination is the only medium for deﬁnitive diagnosis and is
important to rule out malignancies such as leiomyosarcoma. We describe an accidental ﬁnding of a
tumor in the right prostate lobe of a 54 year old man, who was diagnosed with prostatic leiomyoma and
treated with open radical prostatectomy.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).A 54-year old man presented at the ofﬁce for a routine check-up
since his father had recently been diagnosed with prostate cancer.
The patient had no medical history and did not take any medica-
tions. He had little to no lower urinary tract symptoms.
Serum PSA level was within normal ranges (0.9 mg/l). Urinalysis
revealed no abnormalities.
On digital rectal examination an enlarged, atypical right prostate
lobe was palpated. Transrectal ultrasonography conﬁrmed a sus-
picious, hypervascularized mass located in the right prostate lobe
(Fig. 1).
Further investigation with MRI showed a heterogenous mass
with cystic and solid components in the right prostate lobe (Fig. 2).
There was a mass effect on the surrounding tissue, though there
was no sign of invasion of the seminal vesicles. A clear fat plane
between prostate and rectum excluded a tumor of rectal origin.
CT scan did not detect any lymphadenopathy or distant
metastasis.
Prostate biopsy was performed. Histopathological examination
showed proliferating cells with monomorph round to fusiform
nuclei. These cells showed only rare mitotic activity and mild
cellular atypia. A strong vascularization was seen. There were no
signs of necrosis.
Immunohistochemical analysis showed no expression of CD34.
Proliferation rate of Ki67was only 1%-2%. Expression of bcl-2, CD99,
b-catenin and c-kit was not checked. The lesion showed a positive
staining for the myogenic markers desmin and actin. S-100 andoir).
Inc. This is an open access article ucytokeratin staining were negative. The suspect diagnosis was a
stromal tumor of uncertain malignant potential (STUMP) or a low-
grade leiomyomatous tumor.
The patient was treated with an open radical prostatectomy and
extended lymphadenectomy. No frozen sections were taken.
Microscopical examination showed complete resection of a low
grade mesenchymal tumor at the right prostate lobe with a
diameter of 5.5 cm There were less than 5 mitose ﬁgures per 50
high power ﬁelds. Resection margins were clear. There was noFigure 1. Transrectal ultrasonography shows an atypical mass located in the right
prostate lobe.
nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 2. MRI shows a heterogenous mass located in the right prostate lobe.
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resected lymph nodes were reactive and showed no malignancy.
There was a strong immunoreactivity of the proliferating cells
for smooth muscle cell markers desmin and actin. No immunore-
activity for CD117, CD34 and S100 was detected (Fig. 4). The pro-
liferation fraction of Ki67 was about 2 percent.
Based on the immunohistochemical ﬁndings, the diagnosis of a
pure leiomyoma of the prostate was made.
The postoperative course of the patient was uneventful. The
transurethral catheter was removed after 8 days and the patient
regained complete continence after eighteen sessions of pelvic ﬂoor
rehabilitation.
Discussion
A pure leiomyoma of the prostate is a rare tumor. It was ﬁrst
described by Kaufman and Berneike in 1951. Less than 30 cases
about prostatic leiomyoma have been reported ever since.1 A
leiomyoma is a benign tumor, arising from smooth muscle ﬁbers.
Occasionally it can be located in the genitourinary system,
including the kidney, ureter, bladder, urachus, prostate, urethra
and the seminal vesicles.2 More common locations for leiomyo-
mas are the gastrointestinal and the female genital tract.2e4
Chronic inﬂammatory and infectious processes have been pro-
posed as possible pathogenic mechanisms, whereas embryonic
remnants of the Müllerian tube would lie at the origin of a true
leiomyoma of the prostate.2,4 Periglandular prostate smoothmuscleFigure 3. A. HE-staining 100 with bundles of elongated cells. Note the absence of norma
shaped nuclei and inconspicuous nucleolus. Top right a leiomyocyte with slight anisocytosiand the prostate capsule are other possible locations of origin. The
exact mechanism is however still unknown.2,5
Symptoms are similar to those of benign prostatic hyperplasia
and include lower urinary tract symptoms, acute urinary retention,
etc.2 Two cases reported macroscopic hematuria.4,5 Less frequently,
compression of the tumor can cause rectal symptoms.5
Imaging techniques are valuable tools in diagnosing various
tumors of the prostate. A leiomyoma on transrectal ultrasound can
be seen as a hyperechogenic or hypoechogenic well deﬁned mass.
CT images can be very diverse, going from heterogenous to ho-
mogenous masses with or without contrast captation related to the
amount of necrotic tissue.5
Magnetic resonance imaging can differentiate glandular from
leiomyomatous tissue. In general, leiomyomata show a homoge-
nous sign after gadolinium administration. Images can still be very
diverse, related to the amount of histological degenerations within
the lesion.5
Pathologic anatomy examination is the only medium for deﬁn-
itive diagnosis and is important to rule out malignancies such as
leiomyosarcoma.3,5 Immunohistochemical examination of a leio-
myoma shows strong positivity for myogenic markers such as
desmin and actin.2,4,5 The cells can present immunoreactivity
against androgen receptors, variable reactivity to progesterone re-
ceptors but usually no reactivity for estrogen receptors and Ki-67.5
The presence of atypia can implicate a possible risk for malignant
transformation. Atypical cells typically have multinucleate giant
cells with vacuoles.5l prostatic glands. B. HE-staining 400 showing elongated leiomyocytes with spindle
s and anisonucleosis.
Figure 4. A. Strong cytoplasmic smooth muscle actine reactivity (200). B. CD34 staining. Only reactivity in vascular endothelium and not in the proliferating cells (200).
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prostate, which is a very rare entity, and another, more frequent form
where nodules of leiomyomatosis are associated with benign hyper-
plasia. A true leiomyoma of the prostate has no glandular component,
no capsule and no pseudocapsule of more than 1 g.2,5 The smooth
muscle cells of apure leiomyomareplace the entireprostatic tissue. The
recognition of leiomyoma is important because of the potential of
malignancy in some cases, especially in those with nuclear atypia.2,5
Due to the risk of malignant transformation, especially when
cellular atypia is found, all studies in literature conclude that a
complete resection of the tumor is the preferred approach.2,3,5
Transurethral resection, open adenomectomy and radical prosta-
tectomy as a treatment for leiomyomas have all been reported. Due
to the rarity of the tumor, no comparative studies about its treat-
ment are available. No data about the percentage of malignant
transformation were found.
Leiomyoma of the prostate has an excellent prognosis due to its
benign nature and the very low recurrence rate after complete
removal.2,5
Conclusion
Leiomyoma of the prostate is a rare tumor and it should be
included in the differential diagnosis when an atypical mass of theprostate is detected. Histopathological examination is essential for
the deﬁnitive diagnosis. A true leiomyoma of the prostate shows no
glandular prostatic tissue, whereas the presence of cellular atypia
implicates a risk for malignant transformation. When complete
resection is performed and no cellular atypia is found, this tumor
has an excellent prognosis.Conﬂicts of interest
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